<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sexual function in females with pelvic floor and lower urinary tract disorders</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sexual function in females with pelvic floor and lower urinary tract disorders</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Sexual function in females with pelvic floor and lower urinary tract disorders</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Yuko M Komesu, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rebecca G Rogers, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Linda Brubaker, MD, FACOG</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 10, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H29291654"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>In women, sexual dysfunction and pelvic floor disorders (PFDs) are common problems, both of which diminish quality of life. This topic will review the impact of PFDs (pelvic organ prolapse, stress urinary incontinence, urgency urinary incontinence/overactive bladder syndrome, anal incontinence) and their treatment on sexual function. Detailed discussions specific to female sexual function can be found separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5424.html" rel="external">"Overview of sexual dysfunction in females: Epidemiology, risk factors, and evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5485.html" rel="external">"Overview of sexual dysfunction in females: Management"</a>.)</p><p></p><p>Despite increasing awareness of the full range of sexual orientation and practices of individuals identifying as women, the literature has not always recognized nor has it fully described sexual function in all populations of women, particularly regarding pelvic floor and lower urinary tract disorders. The literature regarding these issues, as presented subsequently, has largely been confined to cisgender, heterosexual women. Clinicians are encouraged to have a clear understanding of sexual identity and practices prior to counseling.</p><p>In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. However, we encourage the reader to consider the specific counseling and treatment needs of transgender and gender expansive individuals.</p><p class="headingAnchor" id="H29291375"><span class="h1">SIGNIFICANCE</span><span class="headingEndMark"> — </span>The high prevalence of sexual dysfunction in women with PFDs is significant because sexuality is an important component of overall quality of life [<a href="#rid1">1</a>]. Avoidance of intercourse has been reported to occur in 11 to 45 percent of women with urinary incontinence [<a href="#rid2">2-6</a>]. Women with symptomatic pelvic organ prolapse are less likely to engage in sexual relations and more likely to note sexual dysfunction compared with their asymptomatic counterparts [<a href="#rid2">2,7-10</a>]. In a retrospective review of women undergoing urogynecologic surgery, nearly one-third indicated that they avoided sexual activity because of pelvic floor symptoms [<a href="#rid11">11</a>]. Treatment of PFD can reduce sexual dysfunction. Studies using validated questionnaires report improved sexual function in up to 70 percent of women treated for PFD [<a href="#rid2">2,12,13</a>]. In a qualitative study of women undergoing surgery for PFDs, women rated postoperative sexual complaints as a serious adverse event [<a href="#rid14">14</a>].</p><p>Women with prolapse also report poorer body image [<a href="#rid15">15</a>]. In one study, women with prolapse of stage 2 or greater reported feeling isolated and less attractive and often changed sexual intimacy practices or avoided sexual intimacy altogether [<a href="#rid16">16</a>].</p><p>The extent of sexual dysfunction in women with PFD is difficult to ascertain because of varied definitions of dysfunction and because affected patients may not present for treatment or report the problem [<a href="#rid17">17-26</a>].</p><p class="headingAnchor" id="H55347950"><span class="h1">RESEARCH TOOLS FOR ASSESSMENT OF SEXUAL FUNCTION</span><span class="headingEndMark"> — </span>In research studies, the validated questionnaires specifically developed to assess sexual function in women with urinary incontinence and/or pelvic organ prolapse are the Pelvic Organ Prolapse Incontinence Sexual Questionnaire (PISQ) and its 12-question short form, the PISQ-12 [<a href="#rid13">13,27-30</a>]. Limitations of the PISQ include that it has only been validated in female heterosexual activity, it has not been validated in women with anal incontinence, and it was designed to be administered to women who have engaged in sexual relations in the last six months. An international group of investigators revised the PISQ; the newer version, PISQ-IR, includes both women who report that they are sexually active as well as women who report no sexual activity. Importantly, women with fecal incontinence were included in the validation [<a href="#rid31">31-33</a>]. A summary score has been generated for the PISQ-IR, as well as a cutoff score for impaired sexual function [<a href="#rid34">34,35</a>].</p><p>Multiple other questionnaires exist to evaluate sexual function but are not condition specific. General questionnaires that focus on sexual function include the Female Sexual Function Index (FSFI) and the Sexual History Form 12, which were designed to evaluate sexual function and have undergone validation and reliability testing in a general population [<a href="#rid13">13</a>]. Ongoing limitations in current sexual function questionnaires are that they focus on cisgender women. In addition, general questionnaires are not condition specific and may not be sensitive enough to detect differences due to PFD.</p><p class="headingAnchor" id="H67392630"><span class="h1">CLINICAL FINDINGS AND DIAGNOSIS</span><span class="headingEndMark"> — </span>Patients with PFD typically have urinary or anal incontinence and/or symptoms of pelvic organ prolapse, which include vaginal bulging, pelvic pressure, and splinting or digitation to pass urine or stool [<a href="#rid36">36</a>]. Incontinence is diagnosed with history, physical examination, and simple office tests. Pelvic examination confirms the anatomy of prolapse. (See  <a class="medical medical_review" href="/d/html/8080.html" rel="external">"Pelvic organ prolapse in women: Diagnostic evaluation"</a> and  <a class="medical medical_review" href="/d/html/6874.html" rel="external">"Female urinary incontinence: Evaluation", section on 'Evaluation'</a>.)</p><p>Female sexual dysfunction takes different forms, including lack of sexual desire, impaired arousal, inability to achieve orgasm, or pain with sexual activity. The diagnosis of female sexual dysfunction is based on the presence of diagnostic criteria obtained through a medical and sexual history. To meet criteria for sexual dysfunction, a sexual problem must be recurrent or persistent and cause personal distress or interpersonal difficulty [<a href="#rid37">37</a>]. The international community has published an article outlining terminology to be used in reporting sexual function among women with PFDs [<a href="#rid38">38</a>].</p><p>A detailed discussion of diagnosis of female sexual dysfunction can be found separately. (See  <a class="medical medical_review" href="/d/html/5424.html" rel="external">"Overview of sexual dysfunction in females: Epidemiology, risk factors, and evaluation", section on 'Diagnostic criteria'</a>.)</p><p class="headingAnchor" id="H233962127"><span class="h1">OUR APPROACH</span><span class="headingEndMark"> — </span>Since PFDs affect sexual activity and function, we obtain a sexual history in all women presenting for care, discuss the impact of their disease and treatment options on sexual function, and evaluate for issues that may alter treatment choice. In general, we begin treatment with less invasive options and proceed to surgical options as needed, or if the patient desires a different treatment. (See  <a class="medical medical_review" href="/d/html/5424.html" rel="external">"Overview of sexual dysfunction in females: Epidemiology, risk factors, and evaluation", section on 'Sexual history'</a>.)</p><p class="headingAnchor" id="H342282589"><span class="h2">Assess sexual activity status and sexual function</span><span class="headingEndMark"> — </span>While validated questionnaires to evaluate sexual function exist, most are too long to screen for sexual problems in the clinical setting. A questionnaire consisting of three questions has proved as effective as in-depth interviews in identifying sexual problems and is readily implemented in the clinical setting [<a href="#rid39">39</a>]. Based on this, we ask the following questions:</p><p class="bulletIndent1"><span class="glyph">●</span>Are you sexually active?</p><p class="bulletIndent1"><span class="glyph">●</span>Do you have any problems with sexual activity?</p><p class="bulletIndent1"><span class="glyph">●</span>Do you have any pain with sexual activity?</p><p class="bulletIndent1"><span class="glyph">●</span>Are you in a same sex relationship, heterosexual relationship, or both?</p><p></p><p class="headingAnchor" id="H342282602"><span class="h2">Discuss the impact of PFD and PFD treatment on sexual function</span><span class="headingEndMark"> — </span>Many women and their partners feel that sexual activity is contraindicated or impossible in the setting of prolapse and/or incontinence and that sexual activity will lead to harm of the patient or her partner. We provide reassurance that sexual activity will not harm the patient or the partner, nor worsen the prolapse or incontinence.</p><p>As these are difficult topics for many patients to discuss, we initiate specific conversations regarding sexual function and dysfunction, expectations for sexual function after treatment, the timing of resumption of sexual activity after surgery, the use of lubricants if sexual activity has not been attempted for a prolonged period of time, and what to do if sexual problems arise.</p><p>Following reconstructive vaginal or urinary anti-incontinence surgery, there is no evidence that sexual activity harms repairs, and couples can be reassured that they can resume sexual activity after clearance by their provider. Treatment of the underlying pelvic floor dysfunction typically results in resolution of sexual symptoms specifically associated with the dysfunction. For example, women with coital incontinence are likely to report improvement in coital incontinence after treatment but less likely to report improvement in desire, arousal, and orgasm [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H342282608"><span class="h2">Screen for sexual issues that may impact treatment</span></p><p class="headingAnchor" id="H471318025"><span class="h3">Desire for vaginal sex</span><span class="headingEndMark"> — </span>Desire for future vaginal sexual activity will dictate what type of treatment the patient will be offered. As an example, women who choose colpocleisis, or vaginal obliterative procedures, need to be counseled that future vaginal intercourse is impossible after the procedure. Among women who elect colpocleisis and who are not sexually active, regret is low and satisfaction high [<a href="#rid40">40</a>]. For women who choose a pessary for treatment of their pelvic floor dysfunction, pessary satisfaction is associated with improved sexual function and body image. Among women using a pessary, most remove their pessary during sexual activity secondary to partner concerns about sex with the pessary in place [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H342282614"><span class="h3">Sexual pain</span><span class="headingEndMark"> — </span>Most PFDs are not painful, and women reporting sexual pain disorders such as dyspareunia in the setting of prolapse and/or incontinence are counseled that treatment of their PFD will not necessarily result in improvement in their underlying pain with sex. Conversely, among women with PFD who do not have sexual complaints at baseline, a small but significant number of women report worsened sexual function following treatment, including de novo dyspareunia. As an example, in a meta-analysis of native-tissue pelvic organ prolapse repair, 4 percent of women had new onset dyspareunia [<a href="#rid42">42</a>].</p><p>Because of the association of mesh with pain following surgery, many surgeons advise against the placement of mesh in these women, or placement only following extensive counseling [<a href="#rid43">43</a>]. Likewise, use of a pessary to treat either incontinence or prolapse in the setting of pelvic floor pain is challenging and will likely result in exacerbation of the pain and discontinuation of use of the pessary.</p><p class="headingAnchor" id="H342282627"><span class="h3">Sexual practices</span><span class="headingEndMark"> — </span>In general, varied sexual practices are not contraindicated or of concern in women with pelvic floor dysfunction. For women with anal incontinence, anoreceptive intercourse may be an exception. Up to 20 percent of women regularly engage in anal intercourse [<a href="#rid44">44,45</a>]. While data are limited, studies in men report that anoreceptive intercourse has been associated with decreased sphincter tone and squeeze strength [<a href="#rid46">46</a>],<strong> </strong>and most surgeons would caution against anal intercourse following sphincteroplasty. Analysis of the National Health and Nutrition Examination Survey found that reports of anal incontinence were associated with anoreceptive intercourse [<a href="#rid47">47</a>].</p><p class="headingAnchor" id="H55342532"><span class="h1">PELVIC ORGAN PROLAPSE</span></p><p class="headingAnchor" id="H55342722"><span class="h2">Impact on sexual function</span><span class="headingEndMark"> — </span>Sexual function generally worsens with increasing severity of pelvic organ prolapse (POP) [<a href="#rid9">9</a>]. Women with symptomatic prolapse have lower sexual function scores on validated questionnaires and are less likely to engage in sexual relations compared with their asymptomatic counterparts [<a href="#rid2">2,7,9,10</a>]. The sexual function domains typically affected by symptomatic prolapse include arousal, orgasm, and pain [<a href="#rid9">9,10,48</a>]. One study noted 64 percent of women referred to a urogynecologic practice reported some degree of sexual dysfunction [<a href="#rid49">49</a>]. A different review of 50 studies noted that sexual dysfunction was reported by over half of women with POP while the range of reported obstructed intercourse was 37 to 100 percent [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H55343004"><span class="h2">Impact of pelvic organ prolapse treatment on sexual function</span></p><p class="headingAnchor" id="H55343483"><span class="h3">Nonsurgical treatments</span><span class="headingEndMark"> — </span>Nonsurgical treatment of POP may improve sexual dysfunction in some women and has no harmful effects.</p><p>Pessary use was associated with significantly improved sexual function (specifically desire, lubrication, and sexual satisfaction) compared with pre-pessary function in one observational study that used a validated questionnaire to assess sexual function [<a href="#rid51">51</a>]. In two prospective observational studies that compared pessary use versus surgical therapy in women with prolapse, one study reported equivalent improvement in sexual function and the other reported sexual function was worse with pessary use [<a href="#rid52">52,53</a>].</p><p>The use of pelvic floor muscle training (PFMT) to treat prolapse-associated sexual dysfunction has not been specifically studied, although a systematic review concluded that PFMT benefits prolapse symptoms overall [<a href="#rid54">54</a>]. One retrospective cohort study of 778 women referred for PFMT noted an 80 percent improvement in symptoms of pain (including sexual pain) for those women who completed at least five therapy sessions, but sexual dysfunction was not independently assessed [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H55343571"><span class="h3">Surgical treatment</span><span class="headingEndMark"> — </span>Despite the heterogeneous nature of the anatomy of prolapse (anterior, apical, posterior, or combined) and types of surgical repair (abdominal, vaginal, native tissue, synthetic mesh), surgical repair of POP is generally associated with improvements in rates of sexual dysfunction and dyspareunia [<a href="#rid42">42,56-60</a>]. With regard to sexual function or onset of dyspareunia, similar outcomes have been reported for transvaginal mesh, native tissue repair, biologic grafts, and sacrocolpopexy [<a href="#rid61">61</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sexual dysfunction</strong> – When validated questionnaires are used to assess sexual function before and after prolapse surgery, rather than the isolated symptom of dyspareunia, the majority of studies have reported stable or improved sexual function following surgery [<a href="#rid12">12,48,57,58,62-67</a>]. Some of the variation in response among these studies may reflect the heterogeneity of surgical repairs performed. Improvement in postoperative sexual function following prolapse repair may be related to improved body image as well as reversal of physical symptoms [<a href="#rid16">16,53,68,69</a>]. Body image studies highlight the multifactorial nature of sexual health in women with prolapse and the need to address physical and mental components of sexual health in any treatment plan.</p><p></p><p class="bulletIndent1">Representative studies include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The 2007 CARE trial that evaluated sexual function before and after abdominal sacrocolpopexy reported improved mean Pelvic Organ Prolapse Incontinence Sexual Questionnaire (PISQ) scores one year after prolapse repair surgery [<a href="#rid62">62</a>]. In addition, 45 percent of women in the trial became newly sexually active postoperatively. Seven percent of women who had been sexually active preoperatively became sexually inactive following surgery. Similar trends have been seen with robotic-assisted laparoscopic prolapse repair; 25 women who underwent robotic sacrocolpopexy had good sexual function on the PISQ-12 at baseline, three months, and one year after surgery [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A 2015 meta-analysis of 14 studies of women undergoing native-tissue prolapse repair reported an improvement in sexual function following surgery as assessed by pre- and postoperative questionnaires [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A 2020 systematic review of 67 original studies of multiple POP surgeries reported improved postoperative scores on the PISQ-12 for mixed native tissue repairs, anterior repairs, uterosacral suspensions, sacrospinous suspensions, and sacrocolpopexy; pre- and postoperative scores were similar for posterior repairs, transvaginal mesh, and biologic grafts [<a href="#rid60">60</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dyspareunia </strong>– A systematic review of 67 original studies, including 44 randomly assigned trials, reported lower rates of postoperative dyspareunia across multiple types of POP surgery compared with preoperative rates; reported rates of de novo dyspareunia ranged from 0 to 9 percent with insufficient data available for posterior repair [<a href="#rid60">60</a>]. This review contrasts with earlier studies that reported postoperative dyspareunia rates ranging from 0 to 50 percent following various prolapse repair procedures [<a href="#rid56">56,62-64,67,70-76</a>]. High postoperative dyspareunia rates in early series may have reflected a failure to record de novo dyspareunia, inclusion of individuals with chronic pain syndromes, or use of nonvalidated questionnaires or assessment tools.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Etiology </strong>– Possible mechanisms for de novo dyspareunia include postoperative nerve injury, vaginal narrowing, shortened vaginal length, and use of transvaginal mesh augmentation of the prolapse repair [<a href="#rid72">72-79</a>]. Use of levatorplasty has been associated with de novo postoperative dyspareunia, while posterior repairs performed without levatorplasty report unchanged or improved dyspareunia rates postoperatively [<a href="#rid70">70,80-82</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Impact of transvaginal mesh</strong> – Studies of prolapse repair with transvaginal mesh have reported overall postoperative dyspareunia rates of 9 to 15 percent and de novo dyspareunia rates up to 28 percent [<a href="#rid60">60,75</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>A 2011 systematic review that evaluated studies of vaginal prolapse repair with graft materials reported overall dyspareunia rates of 9 percent (70 studies) and de novo dyspareunia rates of 2 to 28 percent [<a href="#rid75">75</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>A 2020 systematic review that evaluated dyspareunia across multiple types of POP surgeries reported reduced overall dyspareunia rates following transvaginal mesh surgery (22 percent preoperatively versus 15 percent postoperatively) and a de novo dyspareunia rate of 9 percent (14 studies) [<a href="#rid60">60</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For comparison, studies of native tissue repair have reported de novo dyspareunia rates of 1 to 15 percent following various prolapse procedures [<a href="#rid56">56,62,71</a>].</p><p></p><p class="bulletIndent2">Persistently increased rates of complications from transvaginal mesh, including mesh exposure and pain, have resulted in multiple governing agencies advising a limited role for transvaginal mesh and removal of these products from several markets. A detailed discussion can be found elsewhere. (See  <a class="medical medical_review" href="/d/html/115279.html" rel="external">"Transvaginal synthetic mesh: Complications and risk factors"</a>.)</p><p></p><p class="headingAnchor" id="H55344789"><span class="h1">URINARY INCONTINENCE</span></p><p class="headingAnchor" id="H55342756"><span class="h2">Impact of incontinence on sexual function</span><span class="headingEndMark"> — </span>Urinary incontinence, including stress urinary incontinence (SUI) and urgency urinary incontinence (UUI)/overactive bladder (OAB) syndrome (ie, urinary urgency or frequency, with or without incontinence) are all associated with sexual dysfunction [<a href="#rid7">7,83-89</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>All urinary incontinence</strong> – In a questionnaire study of 509 multi-ethnic, middle-aged, community-dwelling US women who were sexually active and experienced at least monthly urinary incontinence, 25 percent reported experiencing urine leakage during sexual activity in the prior three months [<a href="#rid90">90</a>]. Sixteen percent restricted sexual activity because of fear of leakage. Among 1299 women in the Maryland Women's Health Study, urinary incontinence was associated with decreased libido, increased vaginal dryness, and increased dyspareunia independent of age, educational attainment, or race [<a href="#rid91">91</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urgency incontinence</strong> – An observational study of 883 sexually active community-dwelling women reported that pure urgency incontinence was associated with decreased sexual lubrication and more sexual pain, and mixed incontinence was associated with less sexual satisfaction [<a href="#rid92">92</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mixed urinary incontinence</strong> – A study of 510 women with lower urinary tract symptoms including stress, urgency, and mixed incontinence reported that women with mixed incontinence noted poorer sexual function than women with either stress or urgency incontinence alone [<a href="#rid93">93</a>].</p><p></p><p>The impact of interstitial cystitis/bladder pain syndrome on sexual function is discussed separately. (See  <a class="medical medical_review" href="/d/html/8085.html" rel="external">"Interstitial cystitis/bladder pain syndrome: Clinical features and diagnosis", section on 'Associated conditions'</a>.)</p><p class="headingAnchor" id="H3014865562"><span class="h2">Stress urinary incontinence</span></p><p class="headingAnchor" id="H55343011"><span class="h3">Impact of treatment</span><span class="headingEndMark"> — </span>Physical, medical, and surgical therapies for SUI have been associated with improvement in sexual function, although data directly comparing the treatment modalities are limited. All options are discussed when counseling patients regarding treatment choices for urinary incontinence and sexual dysfunction. In general, we suggest conservative management, including pelvic floor therapy or pessary use, prior to proceeding with surgery for urinary incontinence.</p><p class="headingAnchor" id="H55345213"><span class="h3">Nonsurgical treatment</span><span class="headingEndMark"> — </span>Women with urinary incontinence who received pelvic floor muscle training (PFMT) reported improvement in sexual function in observational and randomized trials [<a href="#rid94">94-96</a>]. While the exact mechanism is unknown, PFMT in women with SUI has been reported to improve sexual desire and ability to achieve orgasm, and reduce dyspareunia, which is significant as dyspareunia may be worsened by surgery [<a href="#rid94">94</a>]. A study of 445 women randomly assigned to behavioral therapy (PFMT and continence strategies), pessary therapy, or combined therapy reported that successful treatment of SUI was associated with greater improvement in sexual function, greater reduction in incontinence during sexual activity, and greater reduction in restriction of sexual activity related to fear of incontinence [<a href="#rid97">97</a>]. Among those successfully treated for SUI, improvement in continence during sexual activity was greater in both behavioral therapy groups compared with the pessary-only group.</p><p>Reports of sexual function following SUI treatment with a pessary are sparse. In one prospective analysis, women treated with a pessary reported improved sexual function as measured by the Pelvic Organ Prolapse Incontinence Sexual Questionnaire (PISQ) [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H141516474"><span class="h3">Surgical treatment</span><span class="headingEndMark"> — </span>The impact of SUI surgery on female sexual function varies, but the majority of women have reported unchanged or improved sexual function following multiple types of urinary incontinence procedures [<a href="#rid48">48,98-112</a>]. A systematic review that analyzed studies published prior to 2009 and excluded studies with concomitant prolapse repair reported 55 percent of women had no change in sexual function after surgery, 32 percent had improved sexual function, and 13 percent had worsened sexual function after surgical treatment for SUI [<a href="#rid8">8</a>]. The subanalysis of 1252 women who underwent midurethral sling procedures reported similar results. A later secondary analysis of two trials evaluating four urinary incontinence surgeries reported similar improvement in PISQ scores at two years of follow-up after all four procedures (autologous fascial sling, Burch colposuspension, retropubic midurethral sling, and transobturator midurethral sling) [<a href="#rid111">111</a>].</p><p>Women who reported worsening of sexual function postoperatively often cited de novo dyspareunia as the cause [<a href="#rid98">98,104,108,113-118</a>]. A US Food and Drug Administration literature review of midurethral sling associated dyspareunia rates reported rates of 0.64 to 13.7 percent [<a href="#rid119">119</a>]. The occurrence of preexisting dyspareunia in women with stress incontinence complicates performance of these analyses. Studies have reported the prevalence of preoperative dyspareunia to be as high as 34 to 55 percent [<a href="#rid105">105,108,120</a>].</p><p class="headingAnchor" id="H1915345501"><span class="h3">Impact of obesity</span><span class="headingEndMark"> — </span>Obesity appears to be independently associated with worsening of both sexual dysfunction and urinary incontinence [<a href="#rid121">121-124</a>]. However, the available data on the complex interaction of sexual function, obesity, and urinary incontinence in women are mixed, and further studies are needed to understand the interactions. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>In one study of 366 obese and overweight women randomly assigned to a weight loss regimen, the intervention group lost significantly more weight and had greater reductions in urinary incontinence episodes [<a href="#rid122">122</a>]. However, despite the greater weight loss in the intervention group, a subanalysis of sexually active women did not report improved sexual function compared with controls [<a href="#rid125">125</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast, subsequent studies of bariatric surgery have reported improvement in quality of life, including sexual function, after weight reduction [<a href="#rid126">126,127</a>]. </p><p></p><p class="headingAnchor" id="H3305414599"><span class="h2">Urgency urinary incontinence/Overactive bladder</span></p><p class="headingAnchor" id="H899863442"><span class="h3">Impact of treatment on sexual function</span><span class="headingEndMark"> — </span>Similar to SUI treatments, nonsurgical and surgical treatments of UUI/OAB have been associated with improvement in sexual function. Direct comparisons of different UUI/OAB treatments on sexual function are lacking. As with pelvic floor disorders (PFDs) in general, decisions regarding treatment choice should be based on shared decision-making between patients and providers, with consideration of risks and benefits.</p><p class="headingAnchor" id="H599379745"><span class="h3">Nonsurgical therapy</span><span class="headingEndMark"> — </span>A 2020 review<sup> </sup>that attempted to assess the impact of UUI/OAB treatment on sexual function reported an absence of studies evaluating pelvic floor physical therapy and sexual function in women with OAB [<a href="#rid128">128</a>]. The same review reported pharmacologic treatments improved sexual function in women with OAB, as supported by case series describing <a class="drug drug_general" data-topicid="10313" href="/d/drug information/10313.html" rel="external">solifenacin</a> [<a href="#rid129">129</a>], <a class="drug drug_general" data-topicid="10292" href="/d/drug information/10292.html" rel="external">tolterodine</a> [<a href="#rid130">130</a>], and <a class="drug drug_general" data-topicid="85675" href="/d/drug information/85675.html" rel="external">mirabegron</a> [<a href="#rid131">131</a>] and cohort studies evaluating mirabegron [<a href="#rid132">132</a>], tolterodine [<a href="#rid133">133</a>], and other anticholinergics [<a href="#rid134">134</a>]. A trial comparing tolterodine with placebo among 411 women reported improved OAB symptoms were associated with improved sexual quality of life-female (SQOL-F) and improved pelvic organ prolapse/incontinence sexual questionnaire (PISQ) total scores at 12 weeks [<a href="#rid135">135</a>]. A follow-up study revealed that these affects were sustained at six months [<a href="#rid136">136</a>].</p><p class="headingAnchor" id="H3910633202"><span class="h3">Surgery</span><span class="headingEndMark"> — </span>Studies evaluating surgical or procedural treatment of UUI/OAB are increasing in number and suggest that reduction in symptoms is associated with improved sexual function. Definitive conclusions are limited by the mostly observational study designs and small numbers of included patients.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Onabotulinum toxin injection</strong> – A meta-analysis of sexual function in women with OAB treated with intravesical <a class="drug drug_general" data-topicid="9161" href="/d/drug information/9161.html" rel="external">onabotulinumtoxinA</a> (n = 119) found that total female sexual function index (FSFI) scores improved, with concomitant improvement in desire, lubrication, orgasm, and satisfaction domains [<a href="#rid137">137</a>]. The analysis concluded that though study numbers were relatively small, treatment appeared to positively affect sexual function.<sup> </sup></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Posterior tibial nerve stimulation</strong> – A case series (n = 41) of women treated with posterior tibial nerve stimulation (PTNS) or OAB "dry" (ie, OAB without incontinence) found that FSFI scores improved following treatment [<a href="#rid138">138</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sacral neuromodulation</strong> – Evidence suggesting improved sexual function following sacral neuromodulation (SNM) in women involve even smaller case series. One followed eight women and reported total FSFI scores improved approximately 3 points (22.6 [17.7-25.2] to 25.8 [19.2-29.7], p = 0.02) from baseline to follow-up [<a href="#rid139">139</a>]. Another involving seven women also reported that total FSFI scores improved, as did desire, lubrication, orgasm, satisfaction, pain, and sexual frequency [<a href="#rid140">140</a>].</p><p></p><p class="headingAnchor" id="H55342736"><span class="h1">ANAL INCONTINENCE</span></p><p class="headingAnchor" id="H55342763"><span class="h2">Impact on sexual function</span><span class="headingEndMark"> — </span>Anal incontinence (AI; involuntary loss of flatus and/or feces) and fecal incontinence (involuntary loss of feces, solid or liquid) have been implicated in contributing to sexual dysfunction and are a reason for avoiding sexual relations [<a href="#rid141">141</a>]. Several studies of women with AI reported that women with AI were as likely as women without AI to be sexually active, but they reported less desire and satisfaction with sexual activity [<a href="#rid33">33,142,143</a>]. The association of AI with poor sexual function was consistent across these studies despite the use of different assessment tools (Female Sexual Function Index [FSFI], Pelvic Organ Prolapse Incontinence Sexual Questionnaire 12 [PISQ-12], and PISQ-IR).</p><p class="headingAnchor" id="H55344795"><span class="h2">Impact of anal incontinence treatment on sexual function</span><span class="headingEndMark"> — </span>Few studies have assessed the impact of anal incontinence treatment on sexual function. Almost all evidence is inferential, drawn from analysis of nonobstetric patients with fecal incontinence treated with sphincteroplasty. Several studies of women treated with sphincteroplasty for anal incontinence reported no improvement sexual function scores despite variable improvement in incontinence [<a href="#rid144">144-146</a>]. However, these studies were limited by small sample size and lack of a condition-specific sexual function questionnaire for anal incontinence at the time of these studies [<a href="#rid31">31,32</a>]. There are no studies that have prospectively reported on sexual function in women with fecal incontinence before and after sphincteroplasty.</p><p class="headingAnchor" id="H342282646"><span class="h2">Postoperative counseling</span><span class="headingEndMark"> — </span>As discussed above, there may be an exception for having anoreceptive intercourse after sphincteroplasty that was done for the indication of anal incontinence. Up to 20 percent of women regularly engage in anal intercourse [<a href="#rid44">44,45</a>]. While data are limited, studies in men report that anoreceptive intercourse has been associated with decreased sphincter tone and squeeze strength [<a href="#rid46">46</a>]<strong> </strong>and most surgeons would caution against anal intercourse following sphincteroplasty.</p><p class="headingAnchor" id="H2124115865"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/122273.html" rel="external">"Society guideline links: Pelvic organ prolapse"</a>.)</p><p class="headingAnchor" id="H142797412"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Quality of life</strong> – The high prevalence of sexual dysfunction in women with pelvic floor disorders (PFD) is significant because sexuality is an important component of overall quality of life. Women with pelvic organ prolapse (POP) also report poorer body image. (See <a class="local">'Significance'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Common clinical presentations</strong> – Patients with PFDs typically have urinary or anal incontinence and/or symptoms of POP, which include vaginal bulging, pelvic pressure, and splinting or digitation to pass urine or stool. Urinary incontinence is diagnosed with history, physical examination, and simple office tests. Pelvic examination confirms the anatomy of prolapse. (See <a class="local">'Clinical findings and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact of female sexual dysfunction</strong> – Female sexual dysfunction takes different forms, including lack of sexual desire, impaired arousal, inability to achieve orgasm, or pain with sexual activity. To meet criteria for sexual dysfunction, a sexual problem must be recurrent or persistent and cause personal distress or interpersonal difficulty. (See <a class="local">'Clinical findings and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General approach</strong> – To evaluate these complex patients, we take a sexual history, discuss the impact of both the PFD(s) and treatment on sexual function, and screen for specific issues that may impact treatment choice (eg, dyspareunia or anal incontinence). In general, we begin treatment with less invasive options and proceed to surgical options as needed or if the patient desires a different treatment. (See <a class="local">'Our approach'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pelvic organ prolapse</strong> – Sexual function generally worsens with increasing severity of POP. Nonsurgical treatment of POP with a pessary or pelvic floor muscle training may improve sexual dysfunction in some women and has no harmful effects. Surgical repair of prolapse is generally associated with improvements in sexual dysfunction but may also cause de novo dyspareunia in up to 28 percent of women, especially if levatorplasty or transvaginal mesh is used in the repair. (See <a class="local">'Pelvic organ prolapse'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lower urinary tract disorders </strong>– Lower urinary tract disorders, such as stress urinary incontinence (SUI), urgency urinary incontinence (UUI)/overactive bladder syndrome (OAB), and interstitial cystitis/bladder pain syndrome, are all associated with sexual dysfunction. Improvement in SUI and UUI/OAB symptoms are both generally associated with improvement in sexual function.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>SUI treatment outcomes</strong> – Treatment of SUI with pelvic floor muscle therapy or a pessary may improve sexual function. Meta-analysis of surgical treatments of stress incontinence reported approximately 55 percent of women had unchanged sexual function postoperatively, 32 percent had improved sexual function, and 13 percent had worsened sexual function. (See <a class="local">'Urinary incontinence'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>UUI/OAB treatment outcomes</strong> – Treatment of UUI/OAB is also oftentimes associated with improved sexual function. Medications, including antimuscarinics [<a href="#rid128">128-131,133-136</a>], <a class="drug drug_general" data-topicid="85675" href="/d/drug information/85675.html" rel="external">mirabegron</a> [<a href="#rid132">132</a>], and intravesical botulinum injection [<a href="#rid137">137,138</a>] have also been associated with improved sexual function. The impact of sacral neuromodulation (SNM) on sexual function in patients with OAB is sparse, however, small case series also demonstrate improvement [<a href="#rid128">128,139,140</a>]. (See <a class="local">'Urgency urinary incontinence/Overactive bladder'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Accidental bowel leakage (anal incontinence)</strong> – Accidental bowel leakage may adversely affect sexual function in women with PFDs and has been implicated as a reason for avoidance of sexual activity. The effect of surgical treatment of anal incontinence on sexual function is unclear. (See <a class="local">'Anal incontinence'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Laumann EO, Paik A, Glasser DB, et al. A cross-national study of subjective sexual well-being among older women and men: findings from the Global Study of Sexual Attitudes and Behaviors. Arch Sex Behav 2006; 35:145.</a></li><li><a class="nounderline abstract_t">Rogers GR, Villarreal A, Kammerer-Doak D, Qualls C. Sexual function in women with and without urinary incontinence and/or pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12:361.</a></li><li><a class="nounderline abstract_t">Vierhout ME, Gianotten WL. Mechanisms of urine loss during sexual activity. Eur J Obstet Gynecol Reprod Biol 1993; 52:45.</a></li><li><a class="nounderline abstract_t">Hilton P. Urinary incontinence during sexual intercourse: a common, but rarely volunteered, symptom. Br J Obstet Gynaecol 1988; 95:377.</a></li><li><a class="nounderline abstract_t">Weber AM, Walters MD, Schover LR, Mitchinson A. Sexual function in women with uterovaginal prolapse and urinary incontinence. Obstet Gynecol 1995; 85:483.</a></li><li><a class="nounderline abstract_t">Moran PA, Dwyer PL, Ziccone SP. Urinary leakage during coitus in women. J Obstet Gynaecol 1999; 19:286.</a></li><li><a class="nounderline abstract_t">Barber MD, Visco AG, Wyman JF, et al. Sexual function in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol 2002; 99:281.</a></li><li><a class="nounderline abstract_t">Jha S, Ammenbal M, Metwally M. Impact of incontinence surgery on sexual function: a systematic review and meta-analysis. J Sex Med 2012; 9:34.</a></li><li><a class="nounderline abstract_t">Handa VL, Cundiff G, Chang HH, Helzlsouer KJ. Female sexual function and pelvic floor disorders. Obstet Gynecol 2008; 111:1045.</a></li><li><a class="nounderline abstract_t">Novi JM, Jeronis S, Morgan MA, Arya LA. Sexual function in women with pelvic organ prolapse compared to women without pelvic organ prolapse. J Urol 2005; 173:1669.</a></li><li><a class="nounderline abstract_t">Edenfield AL, Levin PJ, Dieter AA, et al. Sexual activity and vaginal topography in women with symptomatic pelvic floor disorders. J Sex Med 2015; 12:416.</a></li><li><a class="nounderline abstract_t">Rogers RG, Kammerer-Doak D, Darrow A, et al. Does sexual function change after surgery for stress urinary incontinence and/or pelvic organ prolapse? A multicenter prospective study. Am J Obstet Gynecol 2006; 195:e1.</a></li><li><a class="nounderline abstract_t">Kammerer-Doak D. Assessment of sexual function in women with pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20 Suppl 1:S45.</a></li><li><a class="nounderline abstract_t">Dunivan GC, Sussman AL, Jelovsek JE, et al. Gaining the patient perspective on pelvic floor disorders' surgical adverse events. Am J Obstet Gynecol 2019; 220:185.e1.</a></li><li><a class="nounderline abstract_t">Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol 2006; 194:1455.</a></li><li><a class="nounderline abstract_t">Lowder JL, Ghetti C, Nikolajski C, et al. Body image perceptions in women with pelvic organ prolapse: a qualitative study. Am J Obstet Gynecol 2011; 204:441.e1.</a></li><li><a class="nounderline abstract_t">Johanson JF, Lafferty J. Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol 1996; 91:33.</a></li><li><a class="nounderline abstract_t">Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008; 112:970.</a></li><li><a class="nounderline abstract_t">Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281:537.</a></li><li><a class="nounderline abstract_t">Fugl-Meyer KS, Arrhult H, Pharmanson H, et al. A Swedish telephone help-line for sexual problems: a 5-year survey. J Sex Med 2004; 1:278.</a></li><li><a class="nounderline abstract_t">Laumann EO, Nicolosi A, Glasser DB, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17:39.</a></li><li><a class="nounderline abstract_t">Basson R, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 163:888.</a></li><li><a class="nounderline abstract_t">Hayes RD, Dennerstein L, Bennett CM, Fairley CK. What is the "true" prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med 2008; 5:777.</a></li><li><a class="nounderline abstract_t">Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008; 300:1311.</a></li><li><a class="nounderline abstract_t">Swift S, Woodman P, O'Boyle A, et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 2005; 192:795.</a></li><li><a class="nounderline abstract_t">Sung VW, Washington B, Raker CA. Costs of ambulatory care related to female pelvic floor disorders in the United States. Am J Obstet Gynecol 2010; 202:483.e1.</a></li><li><a class="nounderline abstract_t">Rogers RG, Kammerer-Doak D, Villarreal A, et al. A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse. Am J Obstet Gynecol 2001; 184:552.</a></li><li><a class="nounderline abstract_t">Rogers RG, Coates KW, Kammerer-Doak D, et al. A short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12). Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:164.</a></li><li><a class="nounderline abstract_t">Omotosho TB, Rogers RG. Shortcomings/strengths of specific sexual function questionnaires currently used in urogynecology: a literature review. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20 Suppl 1:S51.</a></li><li class="breakAll">World Health Organization. Measuring sexual health: conceptual and practical considerations and related indicators. http://whqlibdoc.who.int/hq/s010/who_rhr_10.12_eng.pdf. (Accessed on December 13, 2011).</li><li><a class="nounderline abstract_t">Rockwood TH, Constantine ML, Adegoke O, et al. The PISQ-IR: considerations in scale scoring and development. Int Urogynecol J 2013; 24:1105.</a></li><li><a class="nounderline abstract_t">Rogers RG, Rockwood TH, Constantine ML, et al. A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR). Int Urogynecol J 2013; 24:1091.</a></li><li><a class="nounderline abstract_t">Pauls RN, Rogers RG, Parekh M, et al. Sexual function in women with anal incontinence using a new instrument: the PISQ-IR. Int Urogynecol J 2015; 26:657.</a></li><li><a class="nounderline abstract_t">Constantine ML, Pauls RN, Rogers RR, Rockwood TH. Validation of a single summary score for the Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR). Int Urogynecol J 2017; 28:1901.</a></li><li><a class="nounderline abstract_t">Grzybowska ME, Futyma K, Wydra D. Identification of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA Revised (PISQ-IR) Cutoff Scores for Impaired Sexual Function in Women with Pelvic Floor Disorders. J Clin Med 2019; 9.</a></li><li class="breakAll">Pelvic Organ Prolapse. In: Williams Gynecology, 2, Hoffman BL, Schorge JO, Schaffer JI, Halvorson LM, Bradshaw KD, Cunningham FG (Eds), The McGraw-Hill Companies, 2012. p.633.</li><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, 2013.</li><li><a class="nounderline abstract_t">Rogers RG, Pauls RN, Thakar R, et al. An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction. Int Urogynecol J 2018; 29:647.</a></li><li><a class="nounderline abstract_t">Plouffe L Jr. Screening for sexual problems through a simple questionnaire. Am J Obstet Gynecol 1985; 151:166.</a></li><li><a class="nounderline abstract_t">Crisp CC, Book NM, Smith AL, et al. Body image, regret, and satisfaction following colpocleisis. Am J Obstet Gynecol 2013; 209:473.e1.</a></li><li><a class="nounderline abstract_t">Meriwether KV, Komesu YM, Craig E, et al. Sexual Function and Pessary Management among Women Using a Pessary for Pelvic Floor Disorders. J Sex Med 2015; 12:2339.</a></li><li><a class="nounderline abstract_t">Jha S, Gray T. A systematic review and meta-analysis of the impact of native tissue repair for pelvic organ prolapse on sexual function. Int Urogynecol J 2015; 26:321.</a></li><li><a class="nounderline abstract_t">Miller D, Milani AL, Sutherland SE, et al. Informed surgical consent for a mesh/graft-augmented vaginal repair of pelvic organ prolapse. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int Urogynecol J 2012; 23 Suppl 1:S33.</a></li><li><a class="nounderline abstract_t">Baggaley RF, Dimitrov D, Owen BN, et al. Heterosexual anal intercourse: a neglected risk factor for HIV? Am J Reprod Immunol 2013; 69 Suppl 1:95.</a></li><li><a class="nounderline abstract_t">Stulhofer A, Ajduković D. A mixed-methods exploration of women's experiences of anal intercourse: meanings related to pain and pleasure. Arch Sex Behav 2013; 42:1053.</a></li><li><a class="nounderline abstract_t">Chun AB, Rose S, Mitrani C, et al. Anal sphincter structure and function in homosexual males engaging in anoreceptive intercourse. Am J Gastroenterol 1997; 92:465.</a></li><li><a class="nounderline abstract_t">Markland AD, Dunivan GC, Vaughan CP, Rogers RG. Anal Intercourse and Fecal Incontinence: Evidence from the 2009-2010 National Health and Nutrition Examination Survey. Am J Gastroenterol 2016; 111:269.</a></li><li><a class="nounderline abstract_t">Pauls RN, Silva WA, Rooney CM, et al. Sexual function after vaginal surgery for pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 2007; 197:622.e1.</a></li><li><a class="nounderline abstract_t">Pauls RN, Segal JL, Silva WA, et al. Sexual function in patients presenting to a urogynecology practice. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:576.</a></li><li><a class="nounderline abstract_t">Harvey MA, Chih HJ, Geoffrion R, et al. International Urogynecology Consultation Chapter 1 Committee 5: relationship of pelvic organ prolapse to associated pelvic floor dysfunction symptoms: lower urinary tract, bowel, sexual dysfunction and abdominopelvic pain. Int Urogynecol J 2021; 32:2575.</a></li><li><a class="nounderline abstract_t">Kuhn A, Bapst D, Stadlmayr W, et al. Sexual and organ function in patients with symptomatic prolapse: are pessaries helpful? Fertil Steril 2009; 91:1914.</a></li><li><a class="nounderline abstract_t">Abdool Z, Thakar R, Sultan AH, Oliver RS. Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse. Int Urogynecol J 2011; 22:273.</a></li><li><a class="nounderline abstract_t">Lowenstein L, Gamble T, Sanses TV, et al. Changes in sexual function after treatment for prolapse are related to the improvement in body image perception. J Sex Med 2010; 7:1023.</a></li><li><a class="nounderline abstract_t">Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2011; :CD003882.</a></li><li><a class="nounderline abstract_t">Starr JA, Drobnis EZ, Lenger S, et al. Outcomes of a comprehensive nonsurgical approach to pelvic floor rehabilitation for urinary symptoms, defecatory dysfunction, and pelvic pain. Female Pelvic Med Reconstr Surg 2013; 19:260.</a></li><li><a class="nounderline abstract_t">Sarlos D, Brandner S, Kots L, et al. Laparoscopic sacrocolpopexy for uterine and post-hysterectomy prolapse: anatomical results, quality of life and perioperative outcome-a prospective study with 101 cases. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:1415.</a></li><li><a class="nounderline abstract_t">Maher C, Feiner B, Baessler K, et al. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2010; :CD004014.</a></li><li><a class="nounderline abstract_t">Geller EJ, Parnell BA, Dunivan GC. Pelvic floor function before and after robotic sacrocolpopexy: one-year outcomes. J Minim Invasive Gynecol 2011; 18:322.</a></li><li><a class="nounderline abstract_t">Azar M, Noohi S, Radfar S, Radfar MH. Sexual function in women after surgery for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:53.</a></li><li><a class="nounderline abstract_t">Antosh DD, Kim-Fine S, Meriwether KV, et al. Changes in Sexual Activity and Function After Pelvic Organ Prolapse Surgery: A Systematic Review. Obstet Gynecol 2020; 136:922.</a></li><li><a class="nounderline abstract_t">Antosh DD, Dieter AA, Balk EM, et al. Sexual function after pelvic organ prolapse surgery: a systematic review comparing different approaches to pelvic floor repair. Am J Obstet Gynecol 2021; 225:475.e1.</a></li><li><a class="nounderline abstract_t">Handa VL, Zyczynski HM, Brubaker L, et al. Sexual function before and after sacrocolpopexy for pelvic organ prolapse. Am J Obstet Gynecol 2007; 197:629.e1.</a></li><li><a class="nounderline abstract_t">Komesu YM, Rogers RG, Kammerer-Doak DN, et al. Posterior repair and sexual function. Am J Obstet Gynecol 2007; 197:101.e1.</a></li><li><a class="nounderline abstract_t">Paraiso MF, Barber MD, Muir TW, Walters MD. Rectocele repair: a randomized trial of three surgical techniques including graft augmentation. Am J Obstet Gynecol 2006; 195:1762.</a></li><li><a class="nounderline abstract_t">Roovers JP, van der Bom A, van Leeuwen JS, et al. Effects of genital prolapse surgery on sexuality. J Psychosom Obstet Gynaecol 2006; 27:43.</a></li><li><a class="nounderline abstract_t">Thakar R, Chawla S, Scheer I, et al. Sexual function following pelvic floor surgery. Int J Gynaecol Obstet 2008; 102:110.</a></li><li><a class="nounderline abstract_t">Glavind K, Larsen T, Lindquist AS. Sexual function in women before and after surgery for pelvic organ prolapse. Acta Obstet Gynecol Scand 2015; 94:80.</a></li><li class="breakAll">Cash TF, Maikkula CL, Yamamiya Y. Baring the body in the bedroom: body image, sexual self-schemas, and sexual functioning among college women and men. Electronic Journal of Human Sexuality 7. http://www.ejhs.org/volume7/bodyimage.html. (Accessed on January 11, 2013).</li><li><a class="nounderline abstract_t">Lowder JL, Ghetti C, Moalli P, et al. Body image in women before and after reconstructive surgery for pelvic organ prolapse. Int Urogynecol J 2010; 21:919.</a></li><li><a class="nounderline abstract_t">Porter WE, Steele A, Walsh P, et al. The anatomic and functional outcomes of defect-specific rectocele repairs. Am J Obstet Gynecol 1999; 181:1353.</a></li><li><a class="nounderline abstract_t">Price N, Slack A, Jackson SR. Laparoscopic sacrocolpopexy: an observational study of functional and anatomical outcomes. Int Urogynecol J 2011; 22:77.</a></li><li><a class="nounderline abstract_t">JEFFCOATE TN. Posterior colpoperineorrhaphy. Am J Obstet Gynecol 1959; 77:490.</a></li><li><a class="nounderline abstract_t">Kahn MA, Stanton SL. Posterior colporrhaphy: its effects on bowel and sexual function. Br J Obstet Gynaecol 1997; 104:82.</a></li><li><a class="nounderline abstract_t">Ulrich D, Dwyer P, Rosamilia A, et al. The effect of vaginal pelvic organ prolapse surgery on sexual function. Neurourol Urodyn 2015; 34:316.</a></li><li><a class="nounderline abstract_t">Abed H, Rahn DD, Lowenstein L, et al. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J 2011; 22:789.</a></li><li><a class="nounderline abstract_t">Committee on Gynecologic Practice. Committee Opinion no. 513: Vaginal placement of synthetic mesh for pelvic organ prolapse. Obstet Gynecol 2011; 118:1459.</a></li><li><a class="nounderline abstract_t">Weber AM, Walters MD, Piedmonte MR. Sexual function and vaginal anatomy in women before and after surgery for pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 2000; 182:1610.</a></li><li class="breakAll">U.S. Food and Drug Administration. FDA News Release. FDA: Surgical placement of mesh to repair pelvic organ prolapse poses risks. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm262752.htm. (Accessed on January 06, 2012).</li><li><a class="nounderline abstract_t">Rogers RG. Sexual function in women with pelvic floor disorders. Can Urol Assoc J 2013; 7:S199.</a></li><li><a class="nounderline abstract_t">Cundiff GW, Weidner AC, Visco AG, et al. An anatomic and functional assessment of the discrete defect rectocele repair. Am J Obstet Gynecol 1998; 179:1451.</a></li><li><a class="nounderline abstract_t">Kenton K, Shott S, Brubaker L. Outcome after rectovaginal fascia reattachment for rectocele repair. Am J Obstet Gynecol 1999; 181:1360.</a></li><li><a class="nounderline abstract_t">Glavind K, Madsen H. A prospective study of the discrete fascial defect rectocele repair. Acta Obstet Gynecol Scand 2000; 79:145.</a></li><li><a class="nounderline abstract_t">Walters MD, Taylor S, Schoenfeld LS. Psychosexual study of women with detrusor instability. Obstet Gynecol 1990; 75:22.</a></li><li><a class="nounderline abstract_t">Clark A, Romm J. Effect of urinary incontinence on sexual activity in women. J Reprod Med 1993; 38:679.</a></li><li><a class="nounderline abstract_t">Yip SK, Chan A, Pang S, et al. The impact of urodynamic stress incontinence and detrusor overactivity on marital relationship and sexual function. Am J Obstet Gynecol 2003; 188:1244.</a></li><li><a class="nounderline abstract_t">Oh SJ, Ku JH, Choo MS, et al. Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder. Int J Urol 2008; 15:62.</a></li><li><a class="nounderline abstract_t">Coksuer H, Ercan CM, Haliloğlu B, et al. Does urinary incontinence subtype affect sexual function? Eur J Obstet Gynecol Reprod Biol 2011; 159:213.</a></li><li><a class="nounderline abstract_t">Sen I, Onaran M, Aksakal N, et al. The impact of urinary incontinence on female sexual function. Adv Ther 2006; 23:999.</a></li><li><a class="nounderline abstract_t">Lim R, Liong ML, Leong WS, et al. Effect of Stress Urinary Incontinence on the Sexual Function of Couples and the Quality of Life of Patients. J Urol 2016; 196:153.</a></li><li><a class="nounderline abstract_t">Munaganuru N, Van Den Eeden SK, Creasman J, et al. Urine leakage during sexual activity among ethnically diverse, community-dwelling middle-aged and older women. Am J Obstet Gynecol 2017; 217:439.e1.</a></li><li><a class="nounderline abstract_t">Handa VL, Harvey L, Cundiff GW, et al. Sexual function among women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 2004; 191:751.</a></li><li><a class="nounderline abstract_t">Su CC, Sun BY, Jiann BP. Association of urinary incontinence and sexual function in women. Int J Urol 2015; 22:109.</a></li><li><a class="nounderline abstract_t">Cameron AP, Smith AR, Lai HH, et al. Bowel function, sexual function, and symptoms of pelvic organ prolapse in women with and without urinary incontinence. Neurourol Urodyn 2018; 37:2586.</a></li><li><a class="nounderline abstract_t">Beji NK, Yalcin O, Erkan HA. The effect of pelvic floor training on sexual function of treated patients. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:234.</a></li><li><a class="nounderline abstract_t">Bø K, Talseth T, Vinsnes A. Randomized controlled trial on the effect of pelvic floor muscle training on quality of life and sexual problems in genuine stress incontinent women. Acta Obstet Gynecol Scand 2000; 79:598.</a></li><li><a class="nounderline abstract_t">Zahariou AG, Karamouti MV, Papaioannou PD. Pelvic floor muscle training improves sexual function of women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:401.</a></li><li><a class="nounderline abstract_t">Handa VL, Whitcomb E, Weidner AC, et al. Sexual function before and after non-surgical treatment for stress urinary incontinence. Female Pelvic Med Reconstr Surg 2011; 17:30.</a></li><li><a class="nounderline abstract_t">Yeni E, Unal D, Verit A, et al. The effect of tension-free vaginal tape (TVT) procedure on sexual function in women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:390.</a></li><li><a class="nounderline abstract_t">Kim DY, Choi JD. Change of sexual function after midurethral sling procedure for stress urinary incontinence. Int J Urol 2008; 15:716.</a></li><li><a class="nounderline abstract_t">Salonia A, Briganti A, Dehò F, et al. Women's sexual dysfunction: a review of the "surgical landscape". Eur Urol 2006; 50:44.</a></li><li><a class="nounderline abstract_t">Ghezzi F, Serati M, Cromi A, et al. Impact of tension-free vaginal tape on sexual function: results of a prospective study. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:54.</a></li><li><a class="nounderline abstract_t">Jha S, Moran P, Greenham H, Ford C. Sexual function following surgery for urodynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:845.</a></li><li><a class="nounderline abstract_t">Pace G, Vicentini C. Female sexual function evaluation of the tension-free vaginal tape (TVT) and transobturator suburethral tape (TOT) incontinence surgery: results of a prospective study. J Sex Med 2008; 5:387.</a></li><li><a class="nounderline abstract_t">Xu Y, Song Y, Huang H. Impact of the tension-free vaginal tape obturator procedure on sexual function in women with stress urinary incontinence. Int J Gynaecol Obstet 2011; 112:187.</a></li><li><a class="nounderline abstract_t">Brubaker L, Chiang S, Zyczynski H, et al. The impact of stress incontinence surgery on female sexual function. Am J Obstet Gynecol 2009; 200:562.e1.</a></li><li><a class="nounderline abstract_t">Barber MD, Kleeman S, Karram MM, et al. Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstet Gynecol 2008; 111:611.</a></li><li><a class="nounderline abstract_t">Filocamo MT, Serati M, Frumenzio E, et al. The impact of mid-urethral slings for the treatment of urodynamic stress incontinence on female sexual function: a multicenter prospective study. J Sex Med 2011; 8:2002.</a></li><li><a class="nounderline abstract_t">Arts-de Jong M, van Altena AM, Aalders CI, et al. Improvement of sexual function after transobturator tape procedure in women with stress urinary incontinence. Gynecol Surg 2011; 8:315.</a></li><li><a class="nounderline abstract_t">Lindquist AS, Glavind K. Long-term follow-up of sexual function in women before and after tension-free vaginal tape operation for stress urinary incontinence. Int Urogynecol J 2016; 27:1571.</a></li><li><a class="nounderline abstract_t">Ward KL, Hilton P, UK and Ireland TVT Trial Group. Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up. BJOG 2008; 115:226.</a></li><li><a class="nounderline abstract_t">Glass Clark SM, Huang Q, Sima AP, Siff LN. Effect of Surgery for Stress Incontinence on Female Sexual Function. Obstet Gynecol 2020; 135:352.</a></li><li><a class="nounderline abstract_t">Zhang Y, Song X, Kang J, et al. Sexual function after tension-free vaginal tape procedure in stress urinary incontinence patients. Menopause 2020; 27:1143.</a></li><li><a class="nounderline abstract_t">Mazouni C, Karsenty G, Bretelle F, et al. Urinary complications and sexual function after the tension-free vaginal tape procedure. Acta Obstet Gynecol Scand 2004; 83:955.</a></li><li><a class="nounderline abstract_t">Jang HC, Jeon JH, Kim DY. Changes in Sexual Function after the Midurethral Sling Procedure for Stress Urinary Incontinence: Long-term Follow-up. Int Neurourol J 2010; 14:170.</a></li><li><a class="nounderline abstract_t">Glavind K, Tetsche MS. Sexual function in women before and after suburethral sling operation for stress urinary incontinence: a retrospective questionnaire study. Acta Obstet Gynecol Scand 2004; 83:965.</a></li><li><a class="nounderline abstract_t">Maaita M, Bhaumik J, Davies AE. Sexual function after using tension-free vaginal tape for the surgical treatment of genuine stress incontinence. BJU Int 2002; 90:540.</a></li><li><a class="nounderline abstract_t">Elzevier HW, Putter H, Delaere KP, et al. Female sexual function after surgery for stress urinary incontinence: transobturator suburethral tape vs. tension-free vaginal tape obturator. J Sex Med 2008; 5:400.</a></li><li><a class="nounderline abstract_t">Elzevier HW, Venema PL, Lycklama á Nijeholt AA. Sexual function after tension-free vaginal tape (TVT) for stress incontinence: results of a mailed questionnaire. Int Urogynecol J Pelvic Floor Dysfunct 2004; 15:313.</a></li><li class="breakAll">2011 Meeting Materials of the Obstetrics and Gynecology Devices Panel. FDA Executive Summary. Surgical mesh for treatment of women with pelvic organ prolapse and stress urinary incontinence. Sept 8-9, 2011 Meeting Materials. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ObstetricsandGynecologyDevices/UCM270402.pdf. (Accessed on January 13, 2012).</li><li><a class="nounderline abstract_t">El-Enen MA, Ragb M, El Gamasy Ael-N, et al. Sexual function among women with stress incontinence after using transobturator vaginal tape, and its correlation with patient's expectations. BJU Int 2009; 104:1118.</a></li><li><a class="nounderline abstract_t">Pace G, Silvestri V, Gualá L, Vicentini C. Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health. Menopause 2009; 16:1188.</a></li><li><a class="nounderline abstract_t">Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 2009; 360:481.</a></li><li><a class="nounderline abstract_t">Melin I, Falconer C, Rössner S, Altman D. Sexual function in obese women: impact of lower urinary tract dysfunction. Int J Obes (Lond) 2008; 32:1312.</a></li><li><a class="nounderline abstract_t">Assimakopoulos K, Panayiotopoulos S, Iconomou G, et al. Assessing sexual function in obese women preparing for bariatric surgery. Obes Surg 2006; 16:1087.</a></li><li><a class="nounderline abstract_t">Huang AJ, Stewart AL, Hernandez AL, et al. Sexual function among overweight and obese women with urinary incontinence in a randomized controlled trial of an intensive behavioral weight loss intervention. J Urol 2009; 181:2235.</a></li><li><a class="nounderline abstract_t">Efthymiou V, Hyphantis T, Karaivazoglou K, et al. The effect of bariatric surgery on patient HRQOL and sexual health during a 1-year postoperative period. Obes Surg 2015; 25:310.</a></li><li><a class="nounderline abstract_t">Strain GW, Kolotkin RL, Dakin GF, et al. The effects of weight loss after bariatric surgery on health-related quality of life and depression. Nutr Diabetes 2014; 4:e132.</a></li><li><a class="nounderline abstract_t">Levy G, Lowenstein L. Overactive Bladder Syndrome Treatments and Their Effect on Female Sexual Function: A Review. Sex Med 2020; 8:1.</a></li><li><a class="nounderline abstract_t">Del Rosso A, Pace G, Di Pierro ED, et al. [Impact of overactive bladder on sexual function in women]. Urologia 2011; 78:200.</a></li><li><a class="nounderline abstract_t">Hajebrahimi S, Azaripour A, Sadeghi-Bazargani H. Tolterodine immediate release improves sexual function in women with overactive bladder. J Sex Med 2008; 5:2880.</a></li><li><a class="nounderline abstract_t">Gubbiotti M, Giannantoni A, Cantaluppi S, et al. The impact of Mirabegron on sexual function in women with idiopathic overactive bladder. BMC Urol 2019; 19:7.</a></li><li><a class="nounderline abstract_t">Zachariou A, Mamoulakis C, Filiponi M, et al. The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study. BMC Urol 2018; 18:61.</a></li><li><a class="nounderline abstract_t">Zachariou A, Filiponi M. The effect of extended release tolterodine used for overactive bladder treatment on female sexual function. Int Braz J Urol 2017; 43:713.</a></li><li><a class="nounderline abstract_t">Cakir SS, Degirmentepe RB, Atalay HA, et al. The effect of overactive bladder treatment with anticholinergics on female sexual function in women: a prospective observational study. Int Urol Nephrol 2019; 51:27.</a></li><li><a class="nounderline abstract_t">Rogers RG, Bachmann G, Scarpero H, et al. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence. Curr Med Res Opin 2009; 25:2159.</a></li><li><a class="nounderline abstract_t">Rogers RG, Omotosho T, Bachmann G, et al. Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 months. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:381.</a></li><li><a class="nounderline abstract_t">Shawer S, Khunda A, Waring GJ, Ballard P. Impact of intravesical onabotulinumtoxinA (Botox) on sexual function in patients with overactive bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J 2022; 33:235.</a></li><li><a class="nounderline abstract_t">Musco S, Serati M, Lombardi G, et al. Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome. J Sex Med 2016; 13:238.</a></li><li><a class="nounderline abstract_t">Gill BC, Swartz MA, Firoozi F, et al. Improved sexual and urinary function in women with sacral nerve stimulation. Neuromodulation 2011; 14:436.</a></li><li><a class="nounderline abstract_t">Pauls RN, Marinkovic SP, Silva WA, et al. Effects of sacral neuromodulation on female sexual function. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:391.</a></li><li><a class="nounderline abstract_t">Moody G, Probert CS, Srivastava EM, et al. Sexual dysfunction amongst women with Crohn's disease: a hidden problem. Digestion 1992; 52:179.</a></li><li><a class="nounderline abstract_t">Imhoff LR, Brown JS, Creasman JM, et al. Fecal incontinence decreases sexual quality of life, but does not prevent sexual activity in women. Dis Colon Rectum 2012; 55:1059.</a></li><li><a class="nounderline abstract_t">Cichowski SB, Komesu YM, Dunivan GC, Rogers RG. The association between fecal incontinence and sexual activity and function in women attending a tertiary referral center. Int Urogynecol J 2013; 24:1489.</a></li><li><a class="nounderline abstract_t">Pauls RN, Silva WA, Rooney CM, et al. Sexual function following anal sphincteroplasty for fecal incontinence. Am J Obstet Gynecol 2007; 197:618.e1.</a></li><li><a class="nounderline abstract_t">Trowbridge ER, Morgan D, Trowbridge MJ, et al. Sexual function, quality of life, and severity of anal incontinence after anal sphincteroplasty. Am J Obstet Gynecol 2006; 195:1753.</a></li><li><a class="nounderline abstract_t">Riss S, Stift A, Teleky B, et al. Long-term anorectal and sexual function after overlapping anterior anal sphincter repair: a case-match study. Dis Colon Rectum 2009; 52:1095.</a></li></ol></div><div id="topicVersionRevision">Topic 16665 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16752118" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A cross-national study of subjective sexual well-being among older women and men: findings from the Global Study of Sexual Attitudes and Behaviors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11795636" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Sexual function in women with and without urinary incontinence and/or pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8119474" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Mechanisms of urine loss during sexual activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3382610" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Urinary incontinence during sexual intercourse: a common, but rarely volunteered, symptom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7898820" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Sexual function in women with uterovaginal prolapse and urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15512297" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Urinary leakage during coitus in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11814510" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Sexual function in women with urinary incontinence and pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21699671" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Impact of incontinence surgery on sexual function: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18448734" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Female sexual function and pelvic floor disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15821545" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Sexual function in women with pelvic organ prolapse compared to women without pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25293781" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Sexual activity and vaginal topography in women with symptomatic pelvic floor disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17074540" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Does sexual function change after surgery for stress urinary incontinence and/or pelvic organ prolapse? A multicenter prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19440782" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Assessment of sexual function in women with pelvic floor dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30612960" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Gaining the patient perspective on pelvic floor disorders' surgical adverse events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16647928" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21292234" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Body image perceptions in women with pelvic organ prolapse: a qualitative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8561140" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Epidemiology of fecal incontinence: the silent affliction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18978095" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Sexual problems and distress in United States women: prevalence and correlates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10022110" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Sexual dysfunction in the United States: prevalence and predictors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16422957" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A Swedish telephone help-line for sexual problems: a 5-year survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15215881" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10688001" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Report of the international consensus development conference on female sexual dysfunction: definitions and classifications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18266650" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : What is the "true" prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18799443" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Prevalence of symptomatic pelvic floor disorders in US women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15746674" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20227673" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Costs of ambulatory care related to female pelvic floor disorders in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11262452" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12955337" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19440783" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Shortcomings/strengths of specific sexual function questionnaires currently used in urogynecology: a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19440783" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Shortcomings/strengths of specific sexual function questionnaires currently used in urogynecology: a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23632799" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The PISQ-IR: considerations in scale scoring and development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23632798" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25392184" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Sexual function in women with anal incontinence using a new instrument: the PISQ-IR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28589290" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Validation of a single summary score for the Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31861568" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Identification of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA Revised (PISQ-IR) Cutoff Scores for Impaired Sexual Function in Women with Pelvic Floor Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31861568" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Identification of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA Revised (PISQ-IR) Cutoff Scores for Impaired Sexual Function in Women with Pelvic Floor Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31861568" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Identification of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA Revised (PISQ-IR) Cutoff Scores for Impaired Sexual Function in Women with Pelvic Floor Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29577166" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4038584" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Screening for sexual problems through a simple questionnaire.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23665244" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Body image, regret, and satisfaction following colpocleisis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26632106" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Sexual Function and Pessary Management among Women Using a Pessary for Pelvic Floor Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25274178" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : A systematic review and meta-analysis of the impact of native tissue repair for pelvic organ prolapse on sexual function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22395291" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Informed surgical consent for a mesh/graft-augmented vaginal repair of pelvic organ prolapse. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23279040" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Heterosexual anal intercourse: a neglected risk factor for HIV?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23519588" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : A mixed-methods exploration of women's experiences of anal intercourse: meanings related to pain and pleasure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9068471" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Anal sphincter structure and function in homosexual males engaging in anoreceptive intercourse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26753893" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Anal Intercourse and Fecal Incontinence: Evidence from the 2009-2010 National Health and Nutrition Examination Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18060954" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Sexual function after vaginal surgery for pelvic organ prolapse and urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16767528" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Sexual function in patients presenting to a urogynecology practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34338825" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : International Urogynecology Consultation Chapter 1 Committee 5: relationship of pelvic organ prolapse to associated pelvic floor dysfunction symptoms: lower urinary tract, bowel, sexual dysfunction and abdominopelvic pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18410935" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Sexual and organ function in patients with symptomatic prolapse: are pessaries helpful?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21161179" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19912488" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Changes in sexual function after treatment for prolapse are related to the improvement in body image perception.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22161382" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Conservative prevention and management of pelvic organ prolapse in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23982573" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Outcomes of a comprehensive nonsurgical approach to pelvic floor rehabilitation for urinary symptoms, defecatory dysfunction, and pelvic pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18536861" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Laparoscopic sacrocolpopexy for uterine and post-hysterectomy prolapse: anatomical results, quality of life and perioperative outcome-a prospective study with 101 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20393938" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Surgical management of pelvic organ prolapse in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21458389" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Pelvic floor function before and after robotic sacrocolpopexy: one-year outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17571198" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Sexual function in women after surgery for pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33030874" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Changes in Sexual Activity and Function After Pelvic Organ Prolapse Surgery: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34087227" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Sexual function after pelvic organ prolapse surgery: a systematic review comparing different approaches to pelvic floor repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18060957" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Sexual function before and after sacrocolpopexy for pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17618777" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Posterior repair and sexual function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17132479" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Rectocele repair: a randomized trial of three surgical techniques including graft augmentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16752875" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Effects of genital prolapse surgery on sexuality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18466905" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Sexual function following pelvic floor surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25287151" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Sexual function in women before and after surgery for pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25287151" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Sexual function in women before and after surgery for pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20440478" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Body image in women before and after reconstructive surgery for pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10601912" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : The anatomic and functional outcomes of defect-specific rectocele repairs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20740358" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Laparoscopic sacrocolpopexy: an observational study of functional and anatomical outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13627047" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Posterior colpoperineorrhaphy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8988702" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Posterior colporrhaphy: its effects on bowel and sexual function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24501075" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The effect of vaginal pelvic organ prolapse surgery on sexual function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21424785" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22105294" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Committee Opinion no. 513: Vaginal placement of synthetic mesh for pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10871485" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Sexual function and vaginal anatomy in women before and after surgery for pelvic organ prolapse and urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10871485" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Sexual function and vaginal anatomy in women before and after surgery for pelvic organ prolapse and urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24523846" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Sexual function in women with pelvic floor disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9855580" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : An anatomic and functional assessment of the discrete defect rectocele repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10601913" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Outcome after rectovaginal fascia reattachment for rectocele repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10696964" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : A prospective study of the discrete fascial defect rectocele repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2296416" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Psychosexual study of women with detrusor instability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8254588" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Effect of urinary incontinence on sexual activity in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12748492" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : The impact of urodynamic stress incontinence and detrusor overactivity on marital relationship and sexual function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18184175" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21733614" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Does urinary incontinence subtype affect sexual function?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17276967" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : The impact of urinary incontinence on female sexual function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26812304" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Effect of Stress Urinary Incontinence on the Sexual Function of Couples and the Quality of Life of Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28602772" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Urine leakage during sexual activity among ethnically diverse, community-dwelling middle-aged and older women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15467535" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Sexual function among women with urinary incontinence and pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25170688" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Association of urinary incontinence and sexual function in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29635702" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Bowel function, sexual function, and symptoms of pelvic organ prolapse in women with and without urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14530833" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : The effect of pelvic floor training on sexual function of treated patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10929962" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Randomized controlled trial on the effect of pelvic floor muscle training on quality of life and sexual problems in genuine stress incontinent women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17876491" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Pelvic floor muscle training improves sexual function of women with stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21572534" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Sexual function before and after non-surgical treatment for stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14676999" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : The effect of tension-free vaginal tape (TVT) procedure on sexual function in women with stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18657201" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Change of sexual function after midurethral sling procedure for stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16650925" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Women's sexual dysfunction: a review of the "surgical landscape".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15973464" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Impact of tension-free vaginal tape on sexual function: results of a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17115231" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Sexual function following surgery for urodynamic stress incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18237371" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Female sexual function evaluation of the tension-free vaginal tape (TVT) and transobturator suburethral tape (TOT) incontinence surgery: results of a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21238965" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Impact of the tension-free vaginal tape obturator procedure on sexual function in women with stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19286143" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : The impact of stress incontinence surgery on female sexual function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18310363" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21762389" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : The impact of mid-urethral slings for the treatment of urodynamic stress incontinence on female sexual function: a multicenter prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21949495" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Improvement of sexual function after transobturator tape procedure in women with stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26992729" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Long-term follow-up of sexual function in women before and after tension-free vaginal tape operation for stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17970791" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31923066" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Effect of Surgery for Stress Incontinence on Female Sexual Function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32986394" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Sexual function after tension-free vaginal tape procedure in stress urinary incontinence patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15453893" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Urinary complications and sexual function after the tension-free vaginal tape procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21179335" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Changes in Sexual Function after the Midurethral Sling Procedure for Stress Urinary Incontinence: Long-term Follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15453895" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Sexual function in women before and after suburethral sling operation for stress urinary incontinence: a retrospective questionnaire study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12230613" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Sexual function after using tension-free vaginal tape for the surgical treatment of genuine stress incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18042216" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Female sexual function after surgery for stress urinary incontinence: transobturator suburethral tape vs. tension-free vaginal tape obturator.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15278249" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Sexual function after tension-free vaginal tape (TVT) for stress incontinence: results of a mailed questionnaire.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15278249" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Sexual function after tension-free vaginal tape (TVT) for stress incontinence: results of a mailed questionnaire.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19302697" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Sexual function among women with stress incontinence after using transobturator vaginal tape, and its correlation with patient's expectations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19458558" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19179316" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Weight loss to treat urinary incontinence in overweight and obese women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18475273" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Sexual function in obese women: impact of lower urinary tract dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16901365" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Assessing sexual function in obese women preparing for bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19296980" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Sexual function among overweight and obese women with urinary incontinence in a randomized controlled trial of an intensive behavioral weight loss intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25085222" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : The effect of bariatric surgery on patient HRQOL and sexual health during a 1-year postoperative period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25177912" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : The effects of weight loss after bariatric surgery on health-related quality of life and depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31604683" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Overactive Bladder Syndrome Treatments and Their Effect on Female Sexual Function: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21786235" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : [Impact of overactive bladder on sexual function in women].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18785896" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Tolterodine immediate release improves sexual function in women with overactive bladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30665388" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : The impact of Mirabegron on sexual function in women with idiopathic overactive bladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29940933" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28199076" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : The effect of extended release tolterodine used for overactive bladder treatment on female sexual function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30448887" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : The effect of overactive bladder treatment with anticholinergics on female sexual function in women: a prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19601704" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19132285" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 months.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35024885" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Impact of intravesical onabotulinumtoxinA (Botox) on sexual function in patients with overactive bladder syndrome: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26803455" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21854492" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Improved sexual and urinary function in women with sacral nerve stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16868656" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Effects of sacral neuromodulation on female sexual function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1459352" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Sexual dysfunction amongst women with Crohn's disease: a hidden problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22965405" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Fecal incontinence decreases sexual quality of life, but does not prevent sexual activity in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23389640" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : The association between fecal incontinence and sexual activity and function in women attending a tertiary referral center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18060952" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Sexual function following anal sphincteroplasty for fecal incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17132478" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Sexual function, quality of life, and severity of anal incontinence after anal sphincteroplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19581852" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Long-term anorectal and sexual function after overlapping anterior anal sphincter repair: a case-match study.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
